Kirsten Harmrolfs
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 19
- Immunology top 5%
- Biotechnology top 5%
- Marine Sponges and Natural Products 5
- Microbial Metabolism and Applications 4
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 3
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 5
-
- Synthetic Organic Chemistry Methods 5
-
- Chemical Synthesis and Analysis 4
- Cancer therapeutics and mechanisms 4
- Co-authors
- Rolf MüllerAndreas KirschningJochen HuehnCarla N. CastroAmrita NandanJenny FreitagNataliya GorinskiMatthias Lochner
- Cited by
- PharmacologyImmunologyBiotechnology
- Journals
- Angewandte Chemie International Edition (8 papers)ChemBioChem (2 papers)ACS Chemical Biology (2 papers)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Kirsten Harmrolfs
32 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Pharmacology 400
- Immunology 474
- Biotechnology 163
- Toxicology 50
- Molecular Medicine 70
Countries citing papers authored by Kirsten Harmrolfs
This map shows the geographic impact of Kirsten Harmrolfs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten Harmrolfs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten Harmrolfs more than expected).
Fields of papers citing papers by Kirsten Harmrolfs
This network shows the impact of papers produced by Kirsten Harmrolfs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten Harmrolfs. The network helps show where Kirsten Harmrolfs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kirsten Harmrolfs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 12 | |
| 3 | 2022 | 18 | |
| 4 | 2021 | 17 | |
| 5 | 2018 | 35 | |
| 6 | 2016 | 23 | |
| 7 | 2015 | 28 | |
| 8 | 2015 | 40 | |
| 9 | De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cellsbreakdown → | 2014 | 700 |
| 10 | 2014 | 33 | |
| 11 | 2014 | 138 | |
| 12 | 2014 | 18 | |
| 13 | 2014 | 19 | |
| 14 | 2012 | 5 | |
| 15 | 2012 | 27 | |
| 16 | 2011 | 29 | |
| 17 | 2011 | 23 | |
| 18 | 2011 | 35 | |
| 19 | 2010 | 15 | |
| 20 | 2008 | 36 |
About Kirsten Harmrolfs
Kirsten Harmrolfs is a scholar working on Pharmacology, Molecular Medicine and Biotechnology, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (19 papers), Antibiotic Resistance in Bacteria (5 papers), Synthetic Organic Chemistry Methods (5 papers), Marine Sponges and Natural Products (5 papers), Chemical Synthesis and Analysis (4 papers), Cancer therapeutics and mechanisms (4 papers), Microbial Metabolism and Applications (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Pharmacology (400 citations), Immunology (474 citations) and Biotechnology (163 citations). Kirsten Harmrolfs has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Rolf Müller, Andreas Kirschning, Jochen Huehn, Carla N. Castro, Amrita Nandan, Jenny Freitag, Nataliya Gorinski, Matthias Lochner, Luciana Berod and Tim Sparwasser. Their work appears in journals such as Angewandte Chemie International Edition, ChemBioChem, ACS Chemical Biology, The Journal of Antibiotics and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.